Feeding and Eating Disorders
Recent clinical, regulatory, research and industry developments relating to this disease.
Hemispheric divergence of interoceptive processing across psychiatric disorders.
Not niche: eating disorders as an example in the dangers of overspecialisation.
A systematic review of weight stigma and disordered eating cognitions and behaviors.
Sleep Pathologies and Eating Disorders: A Crossroad for Neurology, Psychiatry and Nutrition.
Disordered Eating and Eating Disorders in Pediatric Obesity: Assessment and Next Steps.
Current Discoveries and Future Implications of Eating Disorders.
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.
Epidemiology of eating disorders: incidence, prevalence and mortality rates.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 4 clinical trials expected to report results, the earliest in Q1 2029.
- Q1 2029Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: a Pilot Mechanistic Study
- Q4 2029Study of Psilocybin for Anorexia in Young Adults
- Q1 2030Mechanistic Clinical Trial Evaluating the Role of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) in the Antidepressant Mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)
- Q1 2031CELESTE: Comparative Effectiveness Study of behavioraL and Drug-rElated inSomnia Therapies for pEri- and Post-menopausal People
Clinical MilestonesView all 10Hide
- 2026-07-02CPT-SMART for Treatment of PTSD and Cigarette SmokingResults posted
- 2025-12-16Effects of Romosozumab on Bone Density, Markers of Bone Metabolism and Bone Microarchitecture in Women With Anorexia Nervosa: A Pilot StudyResults posted
- 2025-10-10Pain Response Evaluation of a Combined Intervention to Cope Effectively (PRECICE)Results posted
- 2026-06-08CELESTE: Comparative Effectiveness Study of behavioraL and Drug-rElated inSomnia Therapies for pEri- and Post-menopausal PeopleResults expected Q1 2031
- 2026-03-19Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: a Pilot Mechanistic StudyResults expected Q1 2029
- 2026-03-03Study of Psilocybin for Anorexia in Young AdultsResults expected Q4 2029
- 2026-02-17Mechanistic Clinical Trial Evaluating the Role of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) in the Antidepressant Mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)Results expected Q1 2030
- 2026-06-01Personalized Indications for Cognitive Behavioural Therapy and Antidepressants in the Treatment of Major Depressive Disorder and Persistent Depressive DisorderPrimary completion
- 2026-04-30The Effects of Solriamfetol and CBT-I (Alone and in Combination) on Sleep Continuity, Sleepiness, Fatigue, and Performance in Patients With Insomnia DisorderCompleted
- 2025-08-31Partners in Caring for Anxious YouthPrimary completion
- 2026-07-02ClinicalCPT-SMART for Treatment of PTSD and Cigarette SmokingResults posted
- 2026-06-08ClinicalCELESTE: Comparative Effectiveness Study of behavioraL and Drug-rElated inSomnia Therapies for pEri- and Post-menopausal PeopleResults expected Q1 2031
- 2026-06-01ClinicalPersonalized Indications for Cognitive Behavioural Therapy and Antidepressants in the Treatment of Major Depressive Disorder and Persistent Depressive DisorderPrimary completion
- 2026-04-30ClinicalThe Effects of Solriamfetol and CBT-I (Alone and in Combination) on Sleep Continuity, Sleepiness, Fatigue, and Performance in Patients With Insomnia DisorderCompleted
- 2026-03-19ClinicalRepurposing Semaglutide for the Treatment of Cocaine Use Disorder: a Pilot Mechanistic StudyResults expected Q1 2029
- 2026-03-03ClinicalStudy of Psilocybin for Anorexia in Young AdultsResults expected Q4 2029
- 2026-02-17ClinicalMechanistic Clinical Trial Evaluating the Role of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) in the Antidepressant Mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)Results expected Q1 2030
- 2025-12-16ClinicalEffects of Romosozumab on Bone Density, Markers of Bone Metabolism and Bone Microarchitecture in Women With Anorexia Nervosa: A Pilot StudyResults posted
- 2025-10-10ClinicalPain Response Evaluation of a Combined Intervention to Cope Effectively (PRECICE)Results posted
- 2025-08-31ClinicalPartners in Caring for Anxious YouthPrimary completion
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Feeding and Eating Disorders8
- Anorexia Nervosa3
- Bulimia Nervosa3
- Binge-Eating Disorder2
- Bulimia1
- Cost of Illness1
- Gastroenterology1
- Hallucinogens1
Leading journals6
- International journal of environmental research and public health2
- Archives of general psychiatry1
- Body image1
- Current opinion in psychiatry1
- Current psychiatry reports1
- eLife1
Leading researchers8
- Hoek HW2
- van Hoeken D2
- Adamic EM1
- Arcelus J1
- Avery J1
- Bargiacchi A1
- Bellaïche M1
- Bertrand V1
Affiliations (unnormalised)6
- Centenary College of Louisiana1
- Center of Healthy Weight and Nutrition1
- Columbia University1
- Laboratory for Autonomic Neuroscience1
- Laboratory of Brain and Cognition1
- Laureate Institute for Brain Research1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Feeding and eating disorders are a group of conditions marked by physiological and/or psychological disturbances in appetite or food intake. The literature commonly discusses anorexia nervosa, bulimia nervosa, binge eating disorder, and related eating disorders as severe illnesses that can affect physical, psychological, and social functioning.
These disorders are characterized by severe disturbances in eating behavior, often accompanied by distressing thoughts and emotions. The literature also highlights preoccupation with food, body weight, and shape as an important feature in the regulation and maintenance of eating-disorder symptoms.
They are often discussed as developing during adolescence or early adulthood, and they are more commonly diagnosed in young adult females. Weight stigma is associated with disordered eating cognitions and behaviors, including binge eating, body dissatisfaction, dietary restraint, unhealthy weight control behaviors, and drive for thinness.
Treatment typically involves a combination of therapy, nutrition counseling, and medical care. The literature also includes drug therapy and emerging psychedelic-assisted approaches, with preliminary data discussed for ketamine, MDMA, psilocybin, and ayahuasca in some eating disorders.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
A group of disorders characterized by physiological and/or psychological disturbances in appetite or food intake.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.